The use of GAP-43 mRNA quantification in high throughput screening of putative neuroprotective agents in dorsal root ganglion cultures. [electronic resource]
Producer: 20040916Description: 193-5 p. digitalISSN:- 0165-0270
- Animals
- Animals, Newborn
- Cell Culture Techniques -- methods
- Cells, Cultured
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical -- methods
- Fetus
- GAP-43 Protein -- genetics
- Ganglia, Spinal -- cytology
- Gene Expression -- drug effects
- Nerve Degeneration -- drug therapy
- Neurons -- cytology
- Neuroprotective Agents -- pharmacology
- RNA, Messenger -- analysis
- Rats
- Reproducibility of Results
- Reverse Transcriptase Polymerase Chain Reaction -- instrumentation
- Tacrolimus -- pharmacology
- Zalcitabine -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.